Vice President of Development - Military veterans preferred

Description:Texas Biomed is partnering with Lindauer Global Executive Search. Please reach out directly to:Terri Rutter, Assistant Vice President, trutter@lindauerglobal.com orKhushboo Rami-Patel, Consultant, kramipatel@lindauerglobal.comto express your interest in applying for this opportunity or to make a nomination.

The Opportunity:

The Texas Biomedical Research Institute (Texas Biomed) is one of the nation's leading nonprofit, independent research institutes, dedicated to enhancing health and quality of life through transformational biomedical research. Its mission is to pioneer and share scientific breakthroughs that protect you, your families, and the global community from the threat of infectious diseases. The Institute thrives on learning and innovation, bringing together discovery-based science and applied research with an entrepreneurial spirit that produces high-quality findings applicable to a broad range of stakeholders. Its combined research expertise and range of facilities and resources make it a unique enterprise, found nowhere else in North America. The Institute is in an exciting phase of strategic growth, engaging local, regional, national, and international partners in academia, the private sector and government.

Texas Biomed seeks an accomplished development leader with successful fundraising experience in health sciences and/or academic medicine to serve as its Vice President of Development (VP). Reporting to the President and CEO, Larry Schlesinger, M.D., a visionary and proven leader who is highly supportive of fundraising, the VP will set the long-term vision and direction for the development program and team. As a seasoned leader, the VP will bring a collaborative and mentorship-based approach to motivate and coach a team of four highly ambitious and hardworking professionals. The VP will join the Institute during the silent phase of an ambitious multimillion-dollar comprehensive campaign, A Scientific Revolution, and will be critical to ensuring its success through strategic implementation and execution. They will develop new outreach and fundraising strategies while continuing to advance relationships with existing prospects and donors, including Trustees, in order to increase engagement and philanthropic contributions to Texas Biomed.

With an entrepreneurial and creative approach, the VP will bring professional expertise and best practices to the Institute. A successful candidate will be a highly motivated, intellectually curious, and broad thinker with a proven track record in securing major and principal gifts. As a visible member of the internal and external community, the VP must have professional acumen and strong communication skills to successfully engage senior leadership, scientists and faculty, and various groups and constituencies. The ability to collaborate and build relationships across the Institute, within the San Antonio community, and across the state and nationally to successfully build and grow Texas Biomed's fundraising program to its greatest potential is fundamental.

Texas Biomedical Research Institute

The Texas Biomedical Research Institute is a national leader among nonprofit, independent research institutes (within the Association of Independent Research Institutes) working exclusively on infectious diseases threatening our future. Vulnerable populations to infection are a particular focus, including those with chronic inflammatory diseases, diabetes, cardiovascular disease, cancer, and the elderly. Located on a 200-acre campus in San Antonio, Texas, Texas Biomed partners with hundreds of researchers and organizations around the world, targeting advances in the fight against infectious diseases, including AIDS, TB, hepatitis, malaria, Ebola, zika, and parasitic infections, as well as new and emerging threats, such as COVID-19. Founded in 1941, the Institute enjoys tremendous support from city leaders, public and private sector partners and the community. It has also benefited from a diverse range of revenue sources.

Texas Biomed is home to the only privately owned and operated maximum containment Biosafety Level (BSL)-4 facility, which is paired with six BSL3 facilities with a range of technologies including PET-CT imaging, and one of only seven National Primate Research Centers (NPRCs) in the United States funded by the NIH.

The Southwest National Primate Research Center provides specialized facilities and expertise in research with non-human primates to investigators from around the United States and other countries. It maintains nearly 3,000 non-human primates.

Texas Biomed is the nation's only independent research institute with a fully integrated primate research center and the highest-level biosafety laboratories on one campus.

As an independent, nonprofit research institute, Texas Biomedical Research Institute has the flexibility to work with partners worldwide from federal agencies, such as the National Institutes of Health and Department of Defense, to independent researchers to biotechnology and pharmaceutical companies.

Texas Biomed utilizes a team science approach to provide the right expertise, unique resources, and a business model with flexibility, reliability, and speed in mind to generate discoveries that ultimately benefit human health. Current local partnerships include the San Antonio Partnership for Precision Therapeutics and the Vaccine Development Center, which both aim to bring together experts and resources from Texas Biomed, Southwest Research Institute, the University of Texas at San Antonio, and UTHealth to create research opportunities in the areas of precision medicine and vaccine development. Texas Biomed also works closely with UTHealth's Barshop Center for Longevity and Aging and maintains strong relationships with biotechnology companies throughout the city and state.

The researchers at Texas Biomed are working together in three critical programmatic areas of discovery:

Host-Pathogen Interactions (HPI)

The HPI program concentrates on the basic biology of infection in humans and animals and the development of disease. Scientists focus on how an infectious agent such as a parasite, bacteria, virus, or fungus can enter our bodies and/or cells and cause illness. Scientists at Texas Biomed are, for example, determining how Ebola or Mycobacterium tuberculosis can infect cells and cause illness or how HIV can subvert our immune system to persist in our bodies. Disease Intervention and Prevention (DIP)

The DIP program aids in the development of diagnostics, treatments, and vaccines to prevent disease and reduce the severity, if not cure, disease and infection. Scientists at Texas Biomed are, for example, working to develop new vaccines for HIV and Ebola, new drugs for malaria and schistosomiasis, and new diagnostics for tuberculosis.

Population Health (PH)

The PH program aims to identify correlates of disease susceptibility or resistance to infectious diseases on a population level. Examples at Texas Biomed include studying how genetic variation impacts neurological disorders, heart disease, diabetes, and infection.

Vision for Change — 10-year Strategic Plan

In December 2019, Texas Biomed launched a 10-year strategic plan, the Vision for Change. This bold initiative arose from the realization that by 2050 infectious diseases are projected to be the number one killer globally, at a cost of $100 trillion — and that Texas Biomed is well placed to respond.

The Vision for Change is rapidly increasing recognition of the need for the Institution's unparalleled research, new funding, and technological innovations that will help advance the groundbreaking science for which Texas Biomed has become known. As a world leader in infectious disease research and building on the Institution's reputation as a best place to work, the plan is catapulting the Institution ahead on six trajectories: science and technology, organizational structure, training and career development, facilities and infrastructure, culture, and business development.

Development Overview

Texas Biomed's Campaign — A Scientific Revolution:

With the ability to spread faster than ever before, infectious disease threats are growing, especially in the most vulnerable populations. Texas Biomed plans to double its scientists and resources in the coming decade through an ambitious $350 million comprehensive campaign, A Scientific Revolution, to meet this challenge, save lives, and be the world leader in infectious disease.

The Campaign will fund three initiatives.

• People – recruitment of teams of top scientists with specific expertise in infection and dedicated to collaborative scientific approaches to the challenges of infectious diseases, inflammation, and immunity.

• Programs – designing and funding the support systems needed to ensure a best practices organization, training of the next generation of biomedical researchers, and a creative science and related business environment.

• Places – redeveloping the Texas Biomed campus to increase the effectiveness of our research and the collaboration of our scientists.

Significant progress on the campaign has been made over the past five years, including about $100 million invested in enhancements to the Institute's campus. These include a combination of new facilities (such as the two new recently completed additions to our Animal Care Complex) and significant renovations to existing campus spaces leading to increased capabilities, added capacity, and efficiencies. One of the noteworthy investments included the addition of a new 7,500 square feet BSL3 laboratory with imaging capabilities, which was critical in the work we performed to accelerate FDA approval of COVID-19 vaccines and therapies.

During this same time period, the Institute has made progress in other elements of its strategic plan, including hiring talented faculty and staff (employee count has grown from around 360 to about 450), programmatic enhancements (as one example, increasing our educational programming ranging from K–12 to post-doc programs), adding capabilities (new state-of-the-art scientific equipment and information technology resources), and enhancements for our employees (new wellness center, on-site medical clinic, food offerings, etc.) yielding first-quartile employee engagement survey scores. Also, during this period, the Institute's annual grant and contract revenues have grown from around $35 million annually to over $70 million, driven by our highly productive faculty and increased business relationships with the addition of a dedicated business development team in 2020.

Funding for these enhancements has come from a variety of sources, including issuing public debt, selling underutilized real estate assets, federal grant support, local government assistance, and — of course — philanthropy. The next phase of the campaign will focus on securing the necessary resources to provide funding for bringing new critical facilities online and further building out the campus to facilitate the growth envisioned in the strategic plan. Philanthropy will necessarily be called on for heavy lifting to support these plans but will certainly be supplemented by other sources, including another planned debt financing later this year. The priorities for the capital campaign have been finely tuned, including marketing materials and a strong, collaborative Corporate Communications team.

Other Affiliations and Campaigns:

Texas Biomed retains a strong volunteer fundraising support base through longstanding voluntary support groups such as the Texas Biomedical Forum (a supporting group of 600 women who raise resources for pilot studies), the Founder's Council (a group of 350 young community business and social leaders who raise awareness of Texas Biomed's research programs and raise funds for small equipment grants), and The Argyle (a private club comprised of 1400 members who make annual donations together totaling $1.2 million). The support of the philanthropic community led to a successful campaign in 2014 raising over $35 million.

Leadership

Dr. Larry Schlesinger

President/CEO

Larry S. Schlesinger, M.D., is an internationally recognized authority on infectious diseases with a particular interest in tuberculosis and lung biology. He took the reins of leadership as President/CEO of Texas Biomed in 2017 and has led a transformational strategic planning process that is currently being implemented.

Since coming to San Antonio, Dr. Schlesinger has made a huge impact on the San Antonio biomedical research community, particularly building stronger relationships and innovative partnerships with UT Health San Antonio, Southwest Research Institute, the University of Texas at San Antonio, other colleges and universities in the region, and the private sector biomedical landscape. He serves on the boards of Biomed SA and the SA Medical Foundation and has spoken in several citywide venues discussing the virtues of working together to achieve great things.

Dr. Schlesinger also serves as a Professor at Texas Biomed and is Principal Investigator (PI) of several ongoing research grants. He serves as PI for the Southwest National Primate Research Center Base Grant. In 2018, Dr. Schlesinger was named a Healthcare Hero by the San Antonio Business Journal in the area of Outstanding Medical Researcher. In 2021, he was awarded Word Affairs Council of San Antonio International Citizen of the Year.

Dr. Schlesinger earned a B.A. in Biology from Cornell University and M.D. from Rutgers Medical School. He completed his residency in internal medicine at the University of Michigan and clinical and research fellowships in infectious diseases at UCLA. In 1991, he joined the faculty at the University of Iowa, where he served as Fellowship Director for the Division of Infectious Diseases and Associate Chair of the Department of Medicine. In 2002, he moved to the Ohio State University, where he served as Director of the Division of Infectious Diseases, Department of Internal Medicine, until 2011, when he became first chair of Microbial Infection and Immunity. He also founded the university-wide Center for Microbial Interface Biology (now the Infectious Diseases Research Institute).

Dr. Schlesinger is a leading physician scientist whose studies focus on the pathogenesis of tuberculosis and other airborne infectious agents that subvert lung immune mechanisms. His discoveries have led to greater insight into the unique attributes that soluble and cellular components of the innate immune system of humans bring to the microbe-host interface, translating them into drug discovery platforms. He is a prolific scholar, having authored more than 230 peer-reviewed articles, reviews, and chapters in leading textbooks on tuberculosis and lung biology. He is also editor of two books. He has been continuously funded by the NIH and a number of other agencies for 30 years, a member or chair of several NIH study sections (and NIAID council member) and other private and federal agencies, and a Fellow of the AAAS, American Academy of Microbiology, AAP, and IDSA. He has served on many advisory boards for universities, NIH, and FDA among others.

Dr. Schlesinger has placed great emphasis on education and mentoring throughout his career, particularly in clinical and translational research, and has been committed to building strong interdisciplinary academic programs through his leadership on training grants and as part of the Medical Scientist Training Program.

San Antonio, Texas

San Antonio is the second-largest city in Texas, after Houston, with a population of 1.5 million people. San Antonio is home to a vibrant, diverse culture and features iconic landmarks like The Alamo and the River Walk and is home to the NBA's San Antonio Spurs. San Antonio is the headquarters of six Fortune 500 companies including Valero Energy, Andeavor (formerly known as Tesoro Corp), USAA, iHeartMedia, NuStar Energy, and CST Brands, Inc.

Between 2021 and 2022, San Antonio became the third-fastest-growing large city in the United States and is listed as one of America's friendliest cities by Travel + Leisure. With steady job growth, beautiful scenery, and a booming food scene, San Antonio has established its own distinct personality. Mexican, European, Asian, African, and Western traditions blend to create something not found anywhere else in the country.

Requirements:

Vice President of Development

Reporting to and working closely with Texas Biomed President and CEO, Larry Schlesinger, M.D., the VP will be a creative and collaborative member of the senior leadership team, responsible for providing oversight and guidance for all development activities including the comprehensive multimillion-dollar fundraising campaign, A Scientific Revolution.

The VP will be responsible for creating and implementing an effective and efficient fundraising strategy and will provide oversight and guidance in strategic planning, campaign execution, prospect research and identification, data integrity, and special/cultivation events. Through portfolio and staff management, the incumbent will develop strategies to ensure continued support from current donors and identify new relationships and partnerships with individuals and organizations locally and nationally who have an interest in supporting Texas Biomed. The VP is critical to building internal and external relationships and must be able to represent and speak for the organization to all audiences.

Job Description:

• Oversees all aspects of development and fundraising initiatives, programs, and strategies that include annual, major, and principal gift strategy; gift-related policies; stewardship strategy and implementation; planned giving; strategic Board relations; prospect identification; and strategic cultivation events.
• Plans, executes, and regularly reviews the direction of the comprehensive campaign plan.
• Works directly with Texas Biomed leadership to plan and execute cultivation and solicitation strategies of lead prospects.
• Personally manages a strategic portfolio of major gift prospects, engaging with the President and Board members as necessary to yield successful outcomes.
• Leads and coaches a virtual team of development professionals to collaborate on strategies and deliver on goals that qualify, cultivate, solicit, and steward campaign prospects and donors.
• Collaborates with Texas Biomed's communications staff to raise the Institute's visibility and communicate the significance of its research to the general public and the donor community.
• Trains and engages with appropriate Board members, campaign committee, other volunteers, advocates, and Texas Biomed staff.
• Motivates and engages all campaign committee volunteers to stay focused on prospect relationships and action items.
• Serves as the primary resource to the Board of Trustees on all matters related to fundraising and delivers regular reports to the Board on the progress of development efforts.
• Creates and implements strategies to build, expand, and maintain a robust pipeline of prospects and donors in Texas and nationally.
• Responsible for budget and expenditure authority of department.
• Performs other duties as assigned.

Qualifications, Experience, and Skills:

• Bachelor's degree with a preference for those with a Master's degree. CFRE certification is a plus.
• Eight to 10 years professional development and fundraising experience, including development for a research-oriented mission or a similar organization.
• Must have experience working in an entrepreneurial environment.
• Significant campaign experience preferred.
• Demonstrated knowledge and understanding of fundraising concepts and techniques.
• Willingness and ability to learn and utilize donor database.
• Supervisory experience and excellent interpersonal and communication skills. Ability to work collaboratively with all levels of staff, volunteers, donors, and prospective donors.
• Exceptional written, oral, interpersonal, and presentation skills and the ability to effectively interface with senior management, staff, Board members, community leaders, donors, and prospects.
• Philanthropic values and a commitment to service.
• Must be able to travel.
• Outstanding organizational skills and ability to manage multiple tasks simultaneously.
• Familiarity and experience with the Texas philanthropic landscape highly desired.

This position maintains the highest standards of personal and professional integrity and will be evaluated against the following attributes: campaign progress, collegiality and collaborative spirit, independent and discretionary judgment, vision and creativity, attention to detail and follow-through, and effective and efficient use of time.

Texas Biomedical Research Institute provides equal employment opportunities for all qualified employees and applicants without regard to race, color, sex, sexual orientation, gender identity, religion, national origin, disability, veteran status, age, marital status, pregnancy, genetic information, or other legally protected status.

Procedure for Candidacy

Lindauer, a global search and talent firm, has been retained to conduct this search on behalf of Texas Biomedical Research Institute. Consideration of candidates will continue until the position is filled.

Candidates should submit, in confidence, a resume and cover letter. Communications, nominations, applications, and inquiries concerning this search should be directed to Terri Rutter, Assistant Vice President, at trutter@lindauerglobal.com or Khushboo Rami-Patel, Senior Consultant, at kramipatel@lindauerglobal.com.

Prior to submitting your resume for this position, please read it over for accuracy. Lindauer does verify academic credentials for its candidates, and our clients frequently conduct background checks prior to finalizing an offer.

Texas Biomedical Research Institute provides equal employment opportunities for all qualified employees and applicants without regard to race, color, sex, sexual orientation, gender identity, religion, national origin, disability, veteran status, age, marital status, pregnancy, genetic information, or other legally protected status.

PI238613087